Chemicals and Drugs

Cetuximab

A chimeric monoclonal antibody that functions as an ANTINEOPLASTIC AGENT through its binding to the EPIDERMAL GROWTH FACTOR RECEPTOR, where it prevents the binding and signaling action of cell growth and survival factors.

National Library of MedicineMedical Subject Headings2026

Structured Summary

Abstract

A chimeric monoclonal antibody that functions as an ANTINEOPLASTIC AGENT through its binding to the EPIDERMAL GROWTH FACTOR RECEPTOR, where it prevents the binding and signaling action of cell growth and survival factors.

MeSH Record

Classification

Related Concepts

Knowledge Graph

Loading graph…

Drag nodes to rearrange; hover to trace links; click a node to open its page.

Drug Class

Pharmacological Action

MeSH Record

See Also

MeSH Record

Synonyms

5 entry terms
  • C225
  • Erbitux
  • IMC C225
  • IMC-C225
  • MAb C225

MeSH Record

Aspects Covered

24 allowable subheadings

Indexed with the subheadings administration & dosage, adverse effects, analysis, biosynthesis, blood, cerebrospinal fluid, chemistry, classification, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, therapeutic use, toxicity, ultrastructure, urine.

MeSH Record

History Note

2016 (2000)

MeSH Hierarchy

Tree Numbers

AMA Style

References

  1. National Library of Medicine. Cetuximab. Medical Subject Headings (MeSH). 2026. Unique ID D000068818. http://id.nlm.nih.gov/mesh/2026/D000068818
  2. Cetuximab. In: Wikipedia. https://en.wikipedia.org/wiki/Cetuximab
  3. Cetuximab. In: Wikidata. https://www.wikidata.org/wiki/Q420296